UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis

PloS one, 2024-05, Vol.19 (5), p.e0296459-e0296459

2024

Volltextzugriff (PDF)

Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients

Arthritis research & therapy, 2020-12, Vol.22 (1), p.282-282, Article 282

2020

Volltextzugriff (PDF)

Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies

Arthritis research & therapy, 2021-01, Vol.23 (1), p.1-1, Article 1

2021

Volltextzugriff (PDF)

P063: Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 individuals

Genetics in Medicine Open, 2023, Vol.1 (1), p.100082, Article 100082

2023

Volltextzugriff (PDF)

Leveraging genomic instability scores (GIS) to investigate BRCA variants of unknown significance (VUS) in ovarian cancer: An analysis of 14,513 patients in the Myriad Collaborative Research Registry (MCRR)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e17549-e17549

2024

Volltextzugriff (PDF)

Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes

JNCI : Journal of the National Cancer Institute, 2022-07, Vol.114 (7), p.996-1002

2022

Volltextzugriff (PDF)

Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants

Cancer genetics, 2023-11, Vol.278-279, p.84-90

2023

Volltextzugriff (PDF)

High positive predictive value 22q11.2 microdeletion screening by prenatal cell‐free DNA testing that incorporates fetal fraction amplification

Prenatal diagnosis, 2024-07, Vol.44 (8), p.925-935

2024

Volltextzugriff (PDF)

MP60-16 CELL CYCLE PROGRESSION SCORE AND PTEN AS PROGNOSTIC FACTORS FOR METASTASIS IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER OVERALL, AND IN THOSE WHO RECEIVED SALVAGE RADIOTHERAPY

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing

JCO precision oncology, 2023-01, Vol.7 (7), p.e2200415

2023

Volltextzugriff (PDF)

Polygenic risk score calibration and association with breast cancer in diverse ancestries

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10505-10505

2023

Volltextzugriff (PDF)

Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy

The Journal of urology, 2022-12, Vol.208 (6), p.1182-1193

2022

Volltextzugriff (PDF)

Reply by Authors

The Journal of urology, 2022-12, Vol.208 (6), p.1192-1193

2022

Volltextzugriff (PDF)

Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors

Genetics in medicine, 2024-07, Vol.26 (7), p.101128, Article 101128

2024

Volltextzugriff (PDF)

Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancer

Urologic oncology, 2021-06, Vol.39 (6), p.366.e19-366.e28

2021

Volltextzugriff (PDF)

Clinical validity of a gene expression signature in diagnostically uncertain neoplasms

Personalized medicine, 2020-09, Vol.17 (5), p.361-371

2020

Volltextzugriff (PDF)

Abstract PD14-05: PD14-05 Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 women

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD14-05-PD14-05

2023

Volltextzugriff (PDF)

Reply by Authors

The Journal of urology, 2022-12, Vol.208 (6), p.1192-1193

2022

Volltextzugriff (PDF)

Immediate electronystagmography in the diagnosis of the dizzy patient

Annals of emergency medicine, 1993-07, Vol.22 (7), p.1182-1189

1993

Volltextzugriff (PDF)

Application of clinical indicators in the emergency department

JAMA : the journal of the American Medical Association, 1989-12, Vol.262 (24), p.3444

1989

Volltextzugriff (PDF)

Acute pericarditis

The Journal of emergency medicine, 1985, Vol.3 (6), p.457-467

1985

Volltextzugriff (PDF)

Recurrent headache in an elderly patient

The American journal of emergency medicine, 1986, Vol.4 (1), p.40-47

1986

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis

Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients

Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies

P063: Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 individuals

Leveraging genomic instability scores (GIS) to investigate BRCA variants of unknown significance (VUS) in ovarian cancer: An analysis of 14,513 patients in the Myriad Collaborative Research Registry (MCRR)

Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes

Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants

High positive predictive value 22q11.2 microdeletion screening by prenatal cell‐free DNA testing that incorporates fetal fraction amplification

MP60-16 CELL CYCLE PROGRESSION SCORE AND PTEN AS PROGNOSTIC FACTORS FOR METASTASIS IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER OVERALL, AND IN THOSE WHO RECEIVED SALVAGE RADIOTHERAPY

Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing

Polygenic risk score calibration and association with breast cancer in diverse ancestries

Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy

Reply by Authors

Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors

Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancer

Clinical validity of a gene expression signature in diagnostically uncertain neoplasms

Abstract PD14-05: PD14-05 Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 women

Reply by Authors

Immediate electronystagmography in the diagnosis of the dizzy patient

Application of clinical indicators in the emergency department

Acute pericarditis

Recurrent headache in an elderly patient

Suchergebnisse filtern